Endothelin receptor antagonists for the treatment of pulmonary arterial hypertension

Author： O'Callaghan Dermot S Savale Laurent Yaïïci Azzedine Natali Delphine Jaïïs Xavier Parent Florence Montani David Humbert Marc Simonneau Géérald Sitbon Olivier

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.10, 2011-07, pp. : 1585-1596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension: Rationale and Place in Therapy

By Price Laura C. Howard Luke S.G.E.

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 3, 2008-01 ,pp. : 171-185

Adis International

Access to resources Recommend Favorite

Endothelin Receptor Antagonism: Role in the Treatment of Pulmonary Arterial Hypertension Related to Scleroderma

By Kabunga Peter Coghlan Gerry

Drugs, Vol. 68, Iss. 12, 2008-01 ,pp. : 1635-1645

Adis International

Access to resources Recommend Favorite

Sitaxsentan, a selective endothelin-A receptor antagonist for the treatment of pulmonary arterial hypertension

By Horn Evelyn M Widlitz Allison C Barst Robyn J

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 11, 2004-11 ,pp. : 1483-1492

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic potential of endothelin receptor antagonists and nitric oxide donors in pulmonary hypertension

By Tilton Ronald G Brock Tommy A Dixon Richard AF

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. : 1291-1308

Informa Healthcare

Access to resources Recommend Favorite

The Role of Endothelin-1 in Obstructive Sleep Apnea Syndrome and Pulmonary Arterial Hypertension: Pathogenesis and Endothelin-1 Antagonists

Current Medicinal Chemistry, Vol. 17, Iss. 11, 2010-04 ,pp. : 1059-1066

Bentham Science Publishers

Access to resources Recommend Favorite